IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology firm, announced that CEO Fred Schwarzer will partake in a fireside chat at the 2022 RBC Capital Markets Global Healthcare Conference on May 17, 2022, at 9:30 a.m. EST in New York. The event will be live-streamed on the Company’s website, with a replay available for 90 days. IGM Biosciences specializes in developing engineered IgM antibodies and has established a proprietary technology platform to enhance therapeutic use, overcoming previous manufacturing challenges since its inception in 2010.

MOUNTAIN VIEW, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022 at 9:30 a.m. EST in New York.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact
Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

When will Fred Schwarzer speak at the RBC Capital Markets Global Healthcare Conference?

Fred Schwarzer will speak on May 17, 2022, at 9:30 a.m. EST.

Where can I watch the IGM Biosciences webcast of the conference?

The webcast can be viewed on the 'Events and Presentations' page in the Investors section of IGM Biosciences' website.

How long will the IGM Biosciences conference replay be available?

The replay of the conference will be available for 90 days after the event.

What is the focus of IGM Biosciences?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for clinical use.

What has IGM Biosciences achieved since its founding?

Since 2010, IGM Biosciences has developed a proprietary technology platform to facilitate the therapeutic use of IgM antibodies.